SEC Form 4 · accession 0001140361-15-007861
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Junius
Director
Period of report
Feb 14, 2015
Accepted (ET)
Feb 18, 2015 · 6:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Stock UnitF1,F2 | — | Feb 14, 2015 | A | 37 | A | — | — | Common Stock | 37 | 327 | D |
| Non-Qualified Stock Option (right to buy)F1,F3 | $159.08 | Feb 14, 2015 | A | 449 | A | — | Feb 13, 2025 | Common Stock | 449 | 449 | D |
Explanation of responses
- F1This equity grant represents pro rata equity compensation earned by the reporting person as a non-employee Director from his election to the IDEXX Laboratories, Inc. Board of Directors on 03/11/2014 to 05/07/2014, the date of the annual equity grant made to all Directors.
- F2Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest fully on 05/06/2015 and are payable as common stock one year following the Director's resignation from the Board of Directors.
- F3Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vests fully on 05/06/2015.